Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- R&D NEWS IN BRIEF（2）
April 21, 2008
- Orchid of India Announces Entry into Japanese Market
April 21, 2008
- NEW PRODUCTS
April 21, 2008
- Generic Makers to Embark on Mergers, Tie-ups: Mr Sawai
April 21, 2008
- NCC to Take Full Advantage of New System to Provide Advanced Healthcare to More Patients
April 21, 2008
- Doctors Should Collect Information Themselves when Using Generics: Prof. Ogata
April 21, 2008
- Further Spread of Hepatitis C Viral Infections Unlikely: Chugai Seminar
April 21, 2008
- Korosho to Punish Healthcare Providers Who Don't Try to Use More Generics: Mr Nakagaki
April 21, 2008
- Drug Cost Cut by 6% by Generic Substitution in 1st Week of April: Nihon Chouzai
April 21, 2008
- New Prescription Form Is Working Well: Mr Takeda
April 21, 2008
- No More Than 10% of Prescriptions Will Be Substituted with Generics: Dr Muto
April 21, 2008
- PMDA Should Support R&D from Patients' Viewpoints: New PMDA Chief Executive
April 21, 2008
- Opinions Split on Whether Only Pharmacists Should Be Allowed to Manage Stores
April 21, 2008
- TOPICS／Q&A Issued on GL on Drugs Using Autologous Cells
April 21, 2008
- OPINION／How to Get Lucky in Your Pharma Career
April 21, 2008
- LDP Begins Discussions on the Need for a Japanese Version of FDA
April 21, 2008
- LDP Proposes Creation of a Japanese Version of FDA
April 21, 2008
- Chugai Reinforces European Sales Structure
April 14, 2008
- Kirin Pharma, Kyowa Hakko Announce Restructuring of R&D Systems
April 14, 2008
- Mochida to Undertake Challenges in New Fields
April 14, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…